Dermavance Pharmaceuticals Overview

  • Founded
  • 2006

  • Status
  • Private

  • Employees
  • 3

  • Latest Deal Type
  • 2ndary - Private

Dermavance Pharmaceuticals General Information


Developer of anti-aging products. The company focuses on advanced technology applications for skin health and cosmetic dermatology. It markets and sells products directly to dermatologists and aesthetic physicians for in-office dispensing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Personal Products
Other Industries
Primary Office
  • 274 West Lancaster Avenue
  • Suite 200
  • Malvern, PA 19355
  • United States
+1 (484) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dermavance Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 00.00 Completed Generating Revenue
1. Early Stage VC (Series A) 27-May-2008 00.00 00.00 Completed Startup
To view Dermavance Pharmaceuticals’s complete valuation and funding history, request access »

Dermavance Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Keith Greathouse Ph.D Chief Executive Officer, President and Co-founder
John Larosa Chief Financial Officer, Chief Business Officer and Co-founder
Kathleen Sugg Vice President of Marketing & Co-Founder
To view Dermavance Pharmaceuticals’s complete executive team members history, request access »

Dermavance Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial